Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial

The Lancet

Volumn 375, Issue 9714, 2010, Pages 563-571

  Turnbull, Lindsay ^a   Brown, Sarah ^b   Harvey, Ian ^a   Olivier, Catherine ^b   Drew, Phil ^c   Napp, Vicky ^b   Hanby, Andrew ^d   Brown, Julia ^b  

^a HULL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c ROYAL CORNWALL HOSPITAL   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; IMAGING; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY TUMOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION;

EID: 76249103292     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)62070-5     Document Type: Article

References (25)

1. BASO Specialist Group Meeting. An audit of screen detected breast cancer for year of screening April 1998 to May 1999. 2000. NHS Breast Screening Programme and BASO.
2. NHS Breast Screening Programme and the Association of Breast Surgeons. An audit of screen detected breast cancer for year of screening April 2006 to March 2007 (2008). http://www.cancerscreening.nhs.uk/breastscreen/publications/baso2006-2007.pdf (accessed June 11, 2008).
3. Leopold K.A., Recht A., Schnitt S.J., et al. Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. International. Int J Radiat Oncol Biol Phys 16 (1989) 11-16
4. Kurtz J.M., Jacquemier J., Amalric R., et al. Breast-conserving therapy for macroscopically multiple cancers. Ann Surg 212 (1990) 38-44
5. Holland R., Veling S.H., Mravunac M., and Hendriks J.H. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56 (1985) 979-990
6. Hartsell W.F., Recine D.C., Griem K.L., Cobleigh M.A., Witt T.R., and Murthy A.K. Should multicentric disease be an absolute contraindication to the use of breast-conserving therapy?. Int J Radiat Oncol Biol Phys 30 (1994) 49-53
7. Kurtz J.M. How to predict the risk of local relapse in the preserved breast. Recent Results Cancer Res 140 (1996) 263-272
8. Davies J.D., Chinyama C.N., Jones M.G., Astley S.M., Bates S.P., and Kulka J. New avenues in 3-D computerised (stereopathological) imaging of breast cancer (review). Anticancer Res 16 (1996) 3971-3981
9. Esserman L., Hylton N., Yassa L., Barclay J., Frankel S., and Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17 (1999) 110-119
10. Balen F.G., Hall-Craggs M.A., Mumtaz H., Wilkinson I., and Scheidau A. MRI of invasive lobular carcinoma of the breast. Proceedings of Radiology, Birmingham (1997), J Charlesworth & Co, Huddersfield
11. Fischer U., Kopka L., and Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213 (1999) 881-888
12. Tan J.E., Orel S.G., Schnall M.D., Schultz D.J., and Solin L.J. Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol 22 (1999) 414-418
13. Turnbull L.W., Brown S.R., Olivier C., et al. Multi-centre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess 14 (2009) 1-182
14. Fischer U., von H.D., Vosshenrich R., Vieweg I., and Grabbe E. Signal characteristics of malignant and benign lesions in dynamic 2D-MRT of the breast [in German]. Rofo 158 (1993) 287-292
15. Kaiser W.A., and Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170 (1989) 6
16. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 211 (1999) 101-110
17. NHS Cancer Screening Programmes and the Royal College of Pathologists. Pathology Reporting of Breast Disease. 2005: report 58 (2005), NHS Cancer Screening Programmes, Sheffield
18. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16 (1990) 199-208
19. Kind P. The EuroQoL instrument: an index of health-related quality of life. Quality of life and pharmacoeconomics in clinical trials (1996), Lippincott-Raven, Philadelphia
20. Brady M.J., Cella D.F., Mo F., et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 15 (1997) 974-986
21. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
22. Moher D., Schulz K.F., Altman D., and CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.[see comment]. JAMA 285 (2001) 1987-1991
23. International conference on harmonisation harmonised tripartite guideline E9: statistical principles for clinical trials. http://www.ema.europa.eu/pdfs/human/ich/036396en.pdf (accessed Jan 27, 2010).
24. Houssami N., Ciatto S., Macaskill P., et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26 (2008) 3248-3258
25. Houssami N., and Hayes D.F. Should MRI be performed on all women with newly diagnosed, early stage breast cancer?. CA Cancer J Clin 59 (2009) 290-302